measuregroup/AID1801610

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID313084696_AID1801610_PMID_VALUE9 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID104098608_AID1801610_PMID_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID313084695_AID1801610_PMID_VALUE6 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID252628615_AID1801610_PMID_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID313084695_AID1801610_PMID_VALUE7 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID252628615_AID1801610_PMID_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID313084695_AID1801610_PMID_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID313084696_AID1801610_PMID_VALUE8 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID104098608_AID1801610_PMID_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID313084696_AID1801610_PMID_VALUE10
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35462 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35367 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP14416
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title	Radioligand Binding Assay from US Patent US9132134: \"Methods for treating GI tract disorders\"
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID252628615 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID313084695 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID313084696 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID104098608
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1801610

Total number of triples: 21.